Deem Makes Best of Breed Travel Booking and Expense Reporting a Seamless End-to-End Process
May 04, 2017 11:01 am UTC| Business
San Francisco, CA, May 04, 2017 -- Deem, a leading mobile and cloud technology provider for the business travel industry, launched Deem Open Expense today, an API framework that integrates Deem’s Work Fource business...
Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 04, 2017 11:01 am UTC| Business
– Successfully completed two positive Phase 3 pivotal efficacy studies of OLINVO™ (oliceridine injection) – – OLINVO program on track for NDA submission in fourth quarter of 2017 –– Clinical development of TRV250 for...
Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 04, 2017 11:01 am UTC| Business
– Successfully completed two positive Phase 3 pivotal efficacy studies of OLINVO™ (oliceridine injection) – – OLINVO program on track for NDA submission in fourth quarter of 2017 –– Clinical development of TRV250 for...
Shenandoah Telecommunications Company Reports Strong First Quarter 2017 Results
May 04, 2017 11:01 am UTC| Business
- Revenues Increase to $153.9 Million - Operating Income of $10.7 Million EDINBURG, Va., May 04, 2017 -- Shenandoah Telecommunications Company (“Shentel”) (NASDAQ:SHEN) announces financial and operating results for...
Shenandoah Telecommunications Company Reports Strong First Quarter 2017 Results
May 04, 2017 11:01 am UTC| Business
- Revenues Increase to $153.9 Million - Operating Income of $10.7 Million EDINBURG, Va., May 04, 2017 -- Shenandoah Telecommunications Company (“Shentel”) (NASDAQ:SHEN) announces financial and operating results for...
May 04, 2017 11:01 am UTC| Business
ALAMEDA, Calif., May 04, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests to aid in the early detection of cancer, today announced that a Medical Advisory Committee of...
May 04, 2017 11:01 am UTC| Business
ALAMEDA, Calif., May 04, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests to aid in the early detection of cancer, today announced that a Medical Advisory Committee of...